The Biology and Genetics of NEK1-Associated ALS
At a Glance
NEK1-associated ALS (ALS24) involves genetic changes that may disrupt DNA repair, cell transport, and other functions that support motor neurons. A NEK1 variant is not automatically a diagnosis or prediction of ALS; its effect depends on the variant and other factors.
While an ALS diagnosis is clinical, understanding the biology of ALS24—the form associated with the NEK1 gene—can provide a window into what is happening at a cellular level. Unlike some genes that act like a simple “on/off” switch for a disease, NEK1 is part of a complex system that helps your motor neurons stay healthy and repair themselves [1].
It is important to remember that much of this information comes from laboratory and disease-mechanism research; its direct relevance to your individual variant is often still uncertain, and no known environmental action or avoidance strategy has been shown to prevent NEK1-associated ALS.
The Role of NEK1: A Cellular Protector
The NEK1 gene provides instructions for making a protein called a kinase [2]. In the world of biology, kinases act like “middle managers”—they send signals by attaching chemical tags to other proteins to tell them what to do. Laboratory models suggest your NEK1 protein has several critical jobs:
- DNA Repair: Your cells’ DNA is constantly being damaged by normal life processes. NEK1 helps signal the cell to fix these breaks through a process called homologous recombination [2][3].
- The Cell’s Skeleton (Microtubules): Motor neurons are incredibly long cells. They rely on a “highway” system made of microtubules to move nutrients and waste back and forth. NEK1 helps maintain these highways [4].
- Nuclear Import: To function, proteins must move in and out of the cell’s command center (the nucleus). Research shows that when NEK1 isn’t working, this “import/export” system can get jammed [4][5].
- A Partnership with C21ORF2: NEK1 doesn’t work alone. It forms a tight partnership with another protein called C21ORF2. Each one helps stabilize the other; if one is missing, the other may break down [6][7].
Loss-of-Function vs. Missense Variants
Not all changes in the NEK1 gene are the same. Your genetic report likely mentions one of two main types of variants (though others like frameshift variants also exist):
- Loss-of-Function (LoF) Variants: These are like a “stop” sign in the middle of a sentence. They tell the cell to stop making the protein early, resulting in a short, non-functional version or no protein at all. These have the strongest link to ALS risk [8][1].
- Missense Variants: These are like a “typo”—one letter in the genetic code is swapped for another. Some missense variants [9] significantly impair the protein’s work, while others are viewed as susceptibility variants that increase risk but are often found in healthy people too [1][10].
Warning: Functional effects and clinical classifications are variant-specific and can change; you should not try to guess the severity of your disease from the variant name alone.
The “Multi-Hit” Hypothesis: Oligogenic Inheritance
One of the most important things to understand about ALS24 is that researchers hypothesize it often follows an oligogenic pattern. “Oligo” means “few” and “genic” means “genes.”
In many cases, a NEK1 variant is considered one “hit” or risk factor. For ALS to develop, researchers hypothesize a person might need a “second hit”—perhaps another genetic variant (like C9orf72 or SOD1 [11]) or an environmental factor [12][13]. This hypothesis helps explain why one family member with the gene might develop ALS while another does not [14]. Note that C9orf72 and SOD1 can also act independently and have their own age-dependent penetrance [15][16].
Understanding that NEK1 is a “risk” factor rather than a “destiny” can be empowering. It means that researchers are focusing on ways to boost the cell’s natural repair systems and stabilize the “highways” (microtubules) to protect the motor neurons [4]. Progress in this area of biology is the foundation for the next generation of ALS therapies.
Common questions in this guide
What is NEK1-associated ALS (ALS24)?
What does the NEK1 gene do in motor neurons?
How are loss-of-function and missense NEK1 variants different?
Does having a NEK1 variant mean I will develop ALS?
What does the multi-hit or oligogenic hypothesis mean in NEK1-associated ALS?
Can avoiding environmental exposures prevent NEK1-associated ALS?
Should my ALS genetic test look for more than NEK1?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on amyotrophic lateral sclerosis, susceptibility to, 24.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Is my specific NEK1 variant classified as a 'loss-of-function' variant or a 'missense' variant, and why does that matter?
- 2.Was my genetic testing 'comprehensive'—did it look for other genes that might be acting alongside NEK1?
- 3.How does the 'DNA repair' role of NEK1 influence my day-to-day care? Are there specific environmental factors I should be more cautious of?
- 4.Do you have any updates on research or trials specifically targeting the 'microtubule' pathways affected by NEK1?
- 5.If a family member is found to have the same variant but is asymptomatic, how frequently should they be monitored, if at all?
References
References (16)
- 1
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis.
Kenna KP, van Doormaal PT, Dekker AM, et al.
Nature genetics 2016; (48(9)):1037-42 doi:10.1038/ng.3626.
PMID: 27455347 - 2
Nek1 Regulates Rad54 to Orchestrate Homologous Recombination and Replication Fork Stability.
Spies J, Waizenegger A, Barton O, et al.
Molecular cell 2016; (62(6)):903-917 doi:10.1016/j.molcel.2016.04.032.
PMID: 27264870 - 3
Identification of the proteome complement of humanTLK1 reveals it binds and phosphorylates NEK1 regulating its activity.
Singh V, Connelly ZM, Shen X, De Benedetti A
Cell cycle (Georgetown, Tex.) 2017; (16(10)):915-926 doi:10.1080/15384101.2017.1314421.
PMID: 28426283 - 4
Loss of function of the ALS-associated NEK1 kinase disrupts microtubule homeostasis and nuclear import.
Mann JR, McKenna ED, Mawrie D, et al.
Science advances 2023; (9(33)):eadi5548 doi:10.1126/sciadv.adi5548.
PMID: 37585529 - 5
NEK1 loss-of-function mutation induces DNA damage accumulation in ALS patient-derived motoneurons.
Higelin J, Catanese A, Semelink-Sedlacek LL, et al.
Stem cell research 2018; (30()):150-162 doi:10.1016/j.scr.2018.06.005.
PMID: 29929116 - 6
Functional characterization of C21ORF2 association with the NEK1 kinase mutated in human in diseases.
Gregorczyk M, Pastore G, Muñoz I, et al.
Life science alliance 2023; (6(7)) doi:10.26508/lsa.202201740.
PMID: 37188479 - 7
An Amyotrophic Lateral Sclerosis-Associated Mutant of C21ORF2 Is Stabilized by NEK1-Mediated Hyperphosphorylation and the Inability to Bind FBXO3.
Watanabe Y, Nakagawa T, Akiyama T, et al.
iScience 2020; (23(9)):101491 doi:10.1016/j.isci.2020.101491.
PMID: 32891887 - 8
NEK1 mutations and the risk of amyotrophic lateral sclerosis (ALS): a meta-analysis.
Yao L, He X, Cui B, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2021; (42(4)):1277-1285 doi:10.1007/s10072-020-05037-6.
PMID: 33462636 - 9
A rare missense variant impacting NEK1 kinase function is associated with ALS.
Brenner D, Ponomarenko A, Petrut I, et al.
Acta neuropathologica communications 2026; (14(1)).
PMID: 42351313 - 10
NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients.
Nguyen HP, Van Mossevelde S, Dillen L, et al.
Neurobiology of aging 2018; (61()):255.e1-255.e7 doi:10.1016/j.neurobiolaging.2017.08.021.
PMID: 28935222 - 11
Oligogenic variants in NEK1 and ATXN2 in amyotrophic lateral sclerosis: report of two cases and review of the literature.
Roy É, Blais M, Dion P, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2026; 1-9 doi:10.1080/21678421.2026.2685158.
PMID: 42268660 - 12
Exploring NEK1 genetic variability in Italian amyotrophic lateral sclerosis patients.
Pensato V, Peverelli S, Tiloca C, et al.
Journal of neurology 2025; (272(7)):469 doi:10.1007/s00415-025-13153-6.
PMID: 40536530 - 13
Novel variants and cellular studies on patients' primary fibroblasts support a role for NEK1 missense variants in ALS pathogenesis.
Lattante S, Doronzio PN, Conte A, et al.
Human molecular genetics 2021; (30(1)):65-71 doi:10.1093/hmg/ddab015.
PMID: 33445179 - 14
Hand-onset weakness is a common feature of ALS patients with a NEK1 loss-of-function variant.
Tsai YS, Lin KP, Jih KY, et al.
Annals of clinical and translational neurology 2020; (7(6)):965-971 doi:10.1002/acn3.51064.
PMID: 32462798 - 15
ALS in Finland: Major Genetic Variants and Clinical Characteristics of Patients With and Without the C9orf72 Hexanucleotide Repeat Expansion.
Laaksovirta H, Launes J, Jansson L, et al.
Neurology. Genetics 2022; (8(2)):e665 doi:10.1212/NXG.0000000000000665.
PMID: 35295181 - 16
Reduced penetrance of gene variants causing amyotrophic lateral sclerosis.
Douglas AGL, Baralle D
Journal of medical genetics 2024; (61(3)):294-297 doi:10.1136/jmg-2023-109580.
PMID: 38123999
This page is for informational purposes only and does not constitute medical advice. It cannot predict what a specific NEK1 variant means for you; discuss your results with a neurologist or genetic counselor.